greymattersinlife Group

The Intersection of Heart Rate Monitoring and Anticoagulation Therapy

Advancements in wearable technology have revolutionized cardiovascular care, particularly in monitoring heart rate and managing anticoagulation therapy.

The Heart Rate Monitor Market is projected to reach USD 13.3 billion by 2032, growing at a CAGR of 5.3% from 2023 to 2032. Simultaneously, the global anticoagulation market is experiencing significant growth, with projections indicating a rise from USD 27.84 billion in 2025 to USD 53.48 billion by 2033, at a CAGR of 8.50%. This convergence underscores the importance of integrated monitoring systems that can simultaneously assess heart rate and coagulation status, enhancing patient outcomes and streamlining healthcare delivery.